Effective use of gemcitabine in the treatment of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas with portal vein tumor thrombus

18Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

A 74-year-old woman had an undifferentiated carcinoma with osteoclast-like giant cells (UCWOGC) in the body of the pancreas with massive portal vein tumor thrombus (PVTT). Because the PVTT progressed so rapidly into the right portal branch, the patient first underwent distal pancreatectomy and tumor thrombectomy to prevent life-threatening portal venous obstruction. Although a recurrent PVTT had developed early postoperatively, systemic gemcitabine treatment was so effective that it induced complete remission 5 months after the initiation of chemotherapy. The patient continued to be in complete response for 12 months, and has survived for 19 months since surgery. © 2012 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Yoshioka, M., Uchinami, H., Watanabe, G., Takahashi, T., Nakagawa, Y., Andoh, H., … Yamamoto, Y. (2012). Effective use of gemcitabine in the treatment of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas with portal vein tumor thrombus. Internal Medicine, 51(16), 2145–2150. https://doi.org/10.2169/internalmedicine.51.7670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free